SCHEMBL8744125

SCHEMBL8744125

C=C(CC)C(=O)[C@]1(n2cc(C)c(=O)[nH]c2=O)C[C@H](O)[C@@H](CO)O1

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TK1 P04183 5/20 0.38
TK2 O00142 3/20 0.38
TYMP P19971 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3694341 0.86 TK1 (0.43) TK1TYMP
SCHEMBL6536213 0.85 TK1 (0.42) TK1TYMP
SCHEMBL27651863 0.84 TK1 (0.41) TK1TK2TYMP
SCHEMBL28239487 0.84 TK1 (0.41) TK1TYMP
SCHEMBL28293851 0.82 TK1 (0.39) TK1TYMP
SCHEMBL8744135 0.81 TK1 (0.38) TK1TK2
SCHEMBL17224727 0.81 TK1 (0.39) TK1TYMP
SCHEMBL29364921 0.81 TK1 (0.45) TK1
SCHEMBL1145612 0.80 TK2 (0.48) TK1TK2
SCHEMBL5148089 0.80 RNASE1 (0.46) TK1TK2TYMP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0753002-A1 MODIFIED OLIGONUCLEOTIDES AND INTERMEDIATES USEFUL IN NUCLEIC ACID THERAPEUTICS AMGEN INC. (US) 1997-01-15 EP disclosed
WO-1995026972-A1 MODIFIED OLIGONUCLEOTIDES AND INTERMEDIATES USEFUL IN NUCLEIC ACID THERAPEUTICS AMGEN INC. (US) 1995-10-12 WO disclosed